Physician profile
Gerald E Breeden
NPI 1871680900
$1,014.29
in general payments reported to CMS, 2019-2025
26 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $665 · 2022: $146 · 2023: $202.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $202.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $202.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $145.60 | 2023 | Zilretta, Iovera |
| Myovant Sciences INC. | $103.51 | 2021 | |
| Astellas Pharma US INC | $80.31 | 2021 | |
| Clarus Therapeutics INC. | $75.30 | 2021 | |
| Ultragenyx Pharmaceutical INC. | $75.00 | 2022 | |
| Amgen INC. | $57.29 | 2022 | |
| Urogen Pharma, INC. | $44.62 | 2021 | |
| Endo Pharmaceuticals INC. | $38.83 | 2021 | |
| Coloplast Corp | $36.34 | 2021 | |
| Abbvie INC. | $35.52 | 2021-2023 | |
| Axonics, INC. | $31.76 | 2021 | |
| Radius Health, INC. | $28.76 | 2021 | |
| Allergan, INC. | $27.51 | 2021 | |
| Tolmar Pharmaceuticals, INC. | $24.81 | 2021 | |
| Pacira Therapeutics, INC. | $23.51 | 2021 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $19.80 | 2021 | |
| Orthofix Medical, INC. | $19.79 | 2023 | Physio-Stim |
| Antares Pharma, INC. | $19.51 | 2021 | |
| Novartis Pharmaceuticals Corporation | $18.38 | 2021 | |
| Boston Scientific Corporation | $17.72 | 2021 | |
| Olympus America INC. | $17.14 | 2023 | Itind System |
| Myriad Genetic Laboratories, INC. | $16.09 | 2021 | |
| Laborie Medical Technologies Corp. | $14.83 | 2021 | |
| Janssen Biotech, INC. | $14.31 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $14.08 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.97 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gerald Breeden listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.